Discover the world of Kintor, a leading personal care brand that offers a diverse range of premium products for all your skin, hair, and body care needs. Experience the power of innovative and high-quality formulations that enhance your natural beauty. Shop now at Ubuy, the exclusive retailer for Kintor in Pakistan. Read More
Kintor is a biopharmaceutical company that focuses on the development and commercialization of innovative antibody drugs. Their products aim to treat various diseases including cancer and autoimmune disorders.
Kintor was founded in 2009.
The company is headquartered in Suzhou, China.
The founders of Kintor are not publicly known.
In 2016, Kintor received IND approval from the China Food and Drug Administration for their first clinical trial drug, Proxalutamide, for the treatment of prostate cancer.
In 2020, Kintor received emergency use authorization from the Chinese government for the use of Proxalutamide in the treatment of COVID-19.
Kintor is actively involved in research and development collaborations with academic institutions and other pharmaceutical companies to expand their product pipeline.
BeiGene is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative cancer treatments.
Innovent Biologics is a biopharmaceutical company that develops and commercializes high-quality biologic medicines for the treatment of cancer and autoimmune diseases.
Jiangsu Hengrui Medicine is a leading biopharmaceutical company in China, focusing on research, development, manufacturing, and marketing of innovative medications for cancer and other diseases.
Proxalutamide is an investigational drug developed by Kintor for the treatment of prostate cancer. It has also shown potential in the treatment of COVID-19.
GT20029 is another investigational drug being developed by Kintor, targeting androgen receptor-related diseases, such as breast cancer and liver cancer.
Kintor is focused on developing drugs for the treatment of cancer and autoimmune disorders.
Proxalutamide is an investigational drug developed by Kintor for the treatment of prostate cancer. It has also shown potential in the treatment of COVID-19.
Kintor is headquartered in Suzhou, China.
Kintor was founded in 2009 and has since focused on the development and commercialization of innovative antibody drugs.
Some of the competitors of Kintor include BeiGene, Innovent Biologics, and Jiangsu Hengrui Medicine.
Express ShippingFast Delivery
Standard Shipping10+ Business Days